GlassScriptPhysician profile
Jerry G Albujar
NPI 1255863981
$4,206.70
in general payments reported to CMS, 2019-2025
12 companies · $1,040 in 2025
The $1,040 reported for 2025 was more than what 81% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $180 · 2022: $124 · 2023: $2,109 · 2024: $753 · 2025: $1,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,585 · Travel and Lodging: $1,317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,584.92 |
| Travel and Lodging | $1,317.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,506.70 | 2023 | Na |
| Treace Medical Concepts, INC. | $1,035.69 | 2024-2025 | |
| Stryker Corporation | $389.88 | 2023-2025 | Variax, Hoffmann, Viaflow |
| Depuy Synthes Sales INC. | $375.06 | 2023-2024 | Lcp, Fibulink, Hammerlock |
| Kerecis Limited | $335.22 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Abbott Laboratories | $212.64 | 2021-2023 | Proclaim |
| Fortis Surgical, LLC | $84.36 | 2024 | |
| Medtronic, INC. | $80.80 | 2022 | |
| Abbvie INC. | $55.38 | 2021-2023 | Dalvance |
| Organogenesis INC. | $44.78 | 2023 | Puraply |
| Medline Industries LP | $43.31 | 2022 | |
| Linvatec Corporation | $42.88 | 2023 | 5ms, Colink Afx, Colink Vallux |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Albujar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.